{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:34:56Z","timestamp":1787502896420,"version":"build-2736575974"},"reference-count":106,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T00:00:00Z","timestamp":1720828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Prostate cancer ranks among the most prevalent tumours globally. While early detection reduces the likelihood of metastasis, managing advanced cases poses challenges in diagnosis and treatment. Current international guidelines support the concurrent use of 99Tc-Bone Scintigraphy and Contrast-Enhanced Chest and Abdomen CT for the staging of metastatic disease and response assessment. However, emerging evidence underscores the superiority of next-generation imaging techniques including PSMA-PET\/CT and whole-body MRI (WB-MRI). This review explores the relevant scientific literature on the role of WB-MRI in metastatic prostate cancer. This multiparametric imaging technique, combining the high anatomical resolution of standard MRI sequences with functional sequences such as diffusion-weighted imaging (DWI) and bone marrow relative fat fraction (rFF%) has proved effective in comprehensive patient assessment, evaluating local disease, most of the nodal involvement, bone metastases and their complications, and detecting the increasing visceral metastases in prostate cancer. It does have the advantage of avoiding the injection of contrast medium\/radionuclide administration, spares the patient the exposure to ionizing radiation, and lacks the confounder of FLARE described with nuclear medicine techniques. Up-to-date literature regarding the diagnostic capabilities of WB-MRI, though still limited compared to PSMA-PET\/CT, strongly supports its widespread incorporation into standard clinical practice, alongside the latest nuclear medicine techniques.<\/jats:p>","DOI":"10.3390\/cancers16142531","type":"journal-article","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T08:35:17Z","timestamp":1721032517000},"page":"2531","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Multiparametric Whole-Body MRI: A Game Changer in Metastatic Prostate Cancer"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9574-586X","authenticated-orcid":false,"given":"Arrigo","family":"Cattabriga","sequence":"first","affiliation":[{"name":"Department of Radiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Renzetti","sequence":"additional","affiliation":[{"name":"Department of Radiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Galuppi","sequence":"additional","affiliation":[{"name":"Department of Radiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2354-9939","authenticated-orcid":false,"given":"Laura","family":"Bartalena","sequence":"additional","affiliation":[{"name":"Department of Radiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Gaudiano","sequence":"additional","affiliation":[{"name":"Department of Radiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7563-8936","authenticated-orcid":false,"given":"Stefano","family":"Brocchi","sequence":"additional","affiliation":[{"name":"Department of Radiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9126-9229","authenticated-orcid":false,"given":"Alice","family":"Rossi","sequence":"additional","affiliation":[{"name":"Radiology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) \u201cDino Amadori\u201d, 47014 Meldola, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiavina","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"},{"name":"Division of Urology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"},{"name":"Division of Urology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Brunocilla","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"},{"name":"Division of Urology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Spinozzi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"},{"name":"Division of Urology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calogero","family":"Catanzaro","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"},{"name":"Division of Urology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9215-7579","authenticated-orcid":false,"given":"Paolo","family":"Castellucci","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Farolfi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1486-2624","authenticated-orcid":false,"given":"Stefano","family":"Fanti","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"},{"name":"Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tunariu","sequence":"additional","affiliation":[{"name":"Clinical Radiology, Royal Marsden Hospital & Institute of Cancer Research, London SW3 6JJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mosconi","sequence":"additional","affiliation":[{"name":"Department of Radiology, IRCCS Azienda Ospedaliero Universitaria di Bologna, 40138 Bologna, Italy"},{"name":"Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40136 Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,13]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eururo.2018.09.041","article-title":"A Prospective Study of the Association between Physical Activity and Risk of Prostate Cancer Defined by Clinical Features and TMPRSS2:ERG","volume":"76","author":"Pernar","year":"2019","journal-title":"Eur. Urol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(94)80264-5","article-title":"Heterogeneity of prostate cancer in radical prostatectomy specimens","volume":"43","author":"Aihara","year":"1994","journal-title":"Urology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: An autopsy study of 1589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1758835920987654","DOI":"10.1177\/1758835920987654","article-title":"Flare phenomenon in prostate cancer: Recent evidence on new drugs and next generation imaging","volume":"13","author":"Conteduca","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Cornford, P., van den Bergh, R.C.N., Briers, E., Van den Broeck, T., Brunckhorst, O., Darraugh, J., Eberli, D., De Meerleer, G., De Santis, M., and Farolfi, A. (2024). EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur. Urol.","DOI":"10.1016\/j.eururo.2024.03.027"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u2018personalized\u2019 approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.annonc.2020.06.011","article-title":"Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Parker","year":"2020","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol.\/ESMO"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.eururo.2016.05.033","article-title":"METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer","volume":"71","author":"Padhani","year":"2017","journal-title":"Eur. Urol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/jmri.27485","article-title":"Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions","volume":"55","author":"Padhani","year":"2022","journal-title":"J. Magn. Reson. Imaging JMRI"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Int. J. Surg. 2010, 8, 336\u2013341.","DOI":"10.1016\/j.ijsu.2010.02.007"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.eururo.2012.02.020","article-title":"Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer?","volume":"62","author":"Lecouvet","year":"2012","journal-title":"Eur. Urol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/pros.22764","article-title":"One-step TNM staging of high-risk prostate cancer using magnetic resonance imaging (MRI): Toward an upfront simplified \u2018all-in-one\u2019 imaging approach?","volume":"74","author":"Pasoglou","year":"2014","journal-title":"Prostate"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1200\/JCO.2015.64.2702","article-title":"Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations from the Prostate Cancer Clinical Trials Working Group 3","volume":"34","author":"Scher","year":"2016","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004728-199901000-00026","article-title":"Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system","volume":"23","author":"Steinborn","year":"1999","journal-title":"J. Comput. Assist. Tomogr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/jmri.1880080336","article-title":"Whole body turbo STIR MRI in unknown primary tumor detection","volume":"8","author":"Eustace","year":"1998","journal-title":"J. Magn. Reson. Imaging JMRI"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/S0009-9260(99)90830-9","article-title":"Magnetic resonance imaging versus radionuclide scintigraphy in screening for bone metastases","volume":"54","author":"Traill","year":"1999","journal-title":"Clin. Radiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00330-002-1344-z","article-title":"Whole-body MRI using a rolling table platform for the detection of bone metastases","volume":"12","author":"Lauenstein","year":"2002","journal-title":"Eur. Radiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s00330-005-0055-7","article-title":"Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey","volume":"16","author":"Ghanem","year":"2006","journal-title":"Eur. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00330-003-1968-7","article-title":"Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer","volume":"14","author":"Engelhard","year":"2004","journal-title":"Eur. Radiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2214\/AJR.11.7866","article-title":"Whole-body diffusion-weighted MRI: Tips, tricks, and pitfalls","volume":"199","author":"Koh","year":"2012","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnmrs.2017.04.002","article-title":"Recent advances in parallel imaging for MRI","volume":"101","author":"Hamilton","year":"2017","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmri.21339","article-title":"Principles of whole-body continuously-moving-table MRI","volume":"28","author":"Aldefeld","year":"2008","journal-title":"J. Magn. Reson. Imaging JMRI"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mrm.10061","article-title":"Continuously moving table data acquisition method for long FOV contrast-enhanced MRA and whole-body MRI","volume":"47","author":"Kruger","year":"2002","journal-title":"Magn. Reson. Med. Off. J. Soc. Magn. Reson. Med.\/Soc. Magn. Reson. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2214\/AJR.06.1403","article-title":"Diffusion-weighted MRI in the body: Applications and challenges in oncology","volume":"188","author":"Koh","year":"2007","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_27","first-page":"275","article-title":"Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display","volume":"22","author":"Takahara","year":"2004","journal-title":"Radiat. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s11547-021-01392-2","article-title":"Whole-body magnetic resonance imaging (WB-MRI) for cancer screening: Recommendations for use","volume":"126","author":"Petralia","year":"2021","journal-title":"Radiol. Medica"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2214\/ajr.169.5.9353477","article-title":"In-phase and out-of-phase MR imaging of bone marrow: Prediction of neoplasia based on the detection of coexistent fat and water","volume":"169","author":"Disler","year":"1997","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s00330-015-3898-6","article-title":"Chemical shift MRI can aid in the diagnosis of indeterminate skeletal lesions of the spine","volume":"26","author":"Douis","year":"2016","journal-title":"Eur. Radiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3332\/ecancer.2021.1164","article-title":"Whole-body magnetic resonance imaging: Technique, guidelines and key applications","volume":"15","author":"Summers","year":"2021","journal-title":"Ecancermedicalscience"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jcot.2019.05.018","article-title":"Advances in whole body MRI for musculoskeletal imaging: Diffusion-weighted imaging","volume":"10","author":"Lee","year":"2019","journal-title":"J. Clin. Orthop. Trauma"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/10790268.2010.11689685","article-title":"Advances in imaging of vertebral and spinal cord injury","volume":"33","author":"Goldberg","year":"2010","journal-title":"J. Spinal Cord Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s11547-018-0955-7","article-title":"Whole-body magnetic resonance imaging (WB-MRI) in oncology: Recommendations and key uses","volume":"124","author":"Petralia","year":"2019","journal-title":"Radiol. Medica"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejrad.2009.03.045","article-title":"Whole-body MRI for the staging and follow-up of patients with metastasis","volume":"70","author":"Schmidt","year":"2009","journal-title":"Eur. J. Radiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.crad.2013.03.030","article-title":"Prostate MRI: Who, when, and how? Report from a UK consensus meeting","volume":"68","author":"Kirkham","year":"2013","journal-title":"Clin. Radiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/radiol.2503080700","article-title":"Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: Determination on whole-body MR images","volume":"250","author":"Cai","year":"2009","journal-title":"Radiology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1001\/jamaoncol.2017.1968","article-title":"Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysis","volume":"3","author":"Ballinger","year":"2017","journal-title":"JAMA Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1148\/radiol.2019181949","article-title":"Guidelines for Acquisition, Interpretation, and Reporting of Whole-Body MRI in Myeloma: Myeloma Response Assessment and Diagnosis System (MY-RADS)","volume":"291","author":"Messiou","year":"2019","journal-title":"Radiology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"106690","DOI":"10.1016\/j.jmr.2020.106690","article-title":"Phase-constrained reconstruction of high-resolution multi-shot diffusion weighted image","volume":"312","author":"Huang","year":"2020","journal-title":"J. Magn. Reson."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s13244-022-01253-0","article-title":"Implementation of Whole-Body MRI (MY-RADS) within the OPTIMUM\/MUKnine multi-centre clinical trial for patients with myeloma","volume":"13","author":"Rata","year":"2022","journal-title":"Insights Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s00330-018-5813-4","article-title":"Multiparametric whole-body 3.0-T MRI in newly diagnosed intermediate- and high-risk prostate cancer: Diagnostic accuracy and interobserver agreement for nodal and metastatic staging","volume":"29","author":"Johnston","year":"2019","journal-title":"Eur. Radiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.mric.2018.06.004","article-title":"Metastasis Reporting and Data System for Prostate Cancer in Practice","volume":"26","author":"Padhani","year":"2018","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s11547-023-01665-y","article-title":"Patient centered radiology: Investigating 3 Tesla whole body MRI acceptance in cancer patients","volume":"128","author":"Rossi","year":"2023","journal-title":"Radiol. Medica"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1002\/mp.12492","article-title":"Fully automatic, multiorgan segmentation in normal whole body magnetic resonance imaging (MRI), using classification forests (CFs), convolutional neural networks (CNNs), and a multi-atlas (MA) approach","volume":"44","author":"Lavdas","year":"2017","journal-title":"Med. Phys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"W287","DOI":"10.2214\/AJR.13.11818","article-title":"Comparison of apparent diffusion coefficient calculation between two-point and multipoint B value analyses in prostate cancer and benign prostate tissue at 3 T: Preliminary experience","volume":"203","author":"Park","year":"2014","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_47","first-page":"77","article-title":"Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): Inter-observer agreement between readers of different expertise levels","volume":"20","author":"Pricolo","year":"2020","journal-title":"Cancer Imaging Off. Publ. Int. Cancer Imaging Soc."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Van Damme, J., Tombal, B., Collette, L., Van Nieuwenhove, S., Pasoglou, V., G\u00e9rard, T., Jamar, F., Lhommel, R., and Lecouvet, F.E. (2021). Comparison of Ga-Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography Computed Tomography (PET-CT) and Whole-Body Magnetic Resonance Imaging (WB-MRI) with Diffusion Sequences (DWI) in the Staging of Advanced Prostate Cancer. Cancers, 13.","DOI":"10.3390\/cancers13215286"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.crad.2021.09.005","article-title":"Imaging features of the evolving patterns of metastatic prostate cancer","volume":"77","author":"Curcean","year":"2022","journal-title":"Clin. Radiol."},{"key":"ref_50","first-page":"64","article-title":"Whole-body diffusion-weighted MRI of normal lymph nodes: Prospective apparent diffusion coefficient histogram and nodal distribution analysis in a healthy cohort","volume":"21","author":"Donners","year":"2021","journal-title":"Cancer Imaging Off. Publ. Int. Cancer Imaging Soc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1007\/s00259-021-05501-1","article-title":"What\u2019s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns","volume":"48","author":"Ferraro","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1007\/s00330-011-2221-4","article-title":"Diagnosis of bone metastases: A meta-analysis comparing 18FDG PET, CT, MRI and bone scintigraphy","volume":"21","author":"Yang","year":"2011","journal-title":"Eur. Radiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncpuro1190","article-title":"Bone imaging in prostate cancer","volume":"5","author":"Dotan","year":"2008","journal-title":"Nat. Clin. Pract. Urol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"110595","DOI":"10.1016\/j.ejrad.2022.110595","article-title":"Osteolytic or mixed bone metastasis is not uncommon in patients with high-risk prostate cancer","volume":"157","author":"Kurokawa","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"20190286","DOI":"10.1259\/bjr.20190286","article-title":"Machine learning for differentiating metastatic and completely responded sclerotic bone lesion in prostate cancer: A retrospective radiomics study","volume":"92","author":"Acar","year":"2019","journal-title":"Br. J. Radiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","article-title":"Bone imaging in metastatic breast cancer","volume":"22","author":"Hamaoka","year":"2004","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.4329\/wjr.v7.i8.202","article-title":"Imaging of bone metastasis: An update","volume":"7","author":"Carty","year":"2015","journal-title":"World J. Radiol."},{"key":"ref_59","first-page":"329","article-title":"Radiologic measurements of tumor response to treatment: Practical approaches and limitations","volume":"28","author":"Suzuki","year":"2008","journal-title":"Radiogr. A Rev. Publ. Radiol. Soc. N. Am. Inc"},{"key":"ref_60","first-page":"741","article-title":"The diagnostic imaging of bone metastases","volume":"111","author":"Heindel","year":"2014","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1080\/00365590310008091","article-title":"MRI of the skeleton in prostate cancer staging","volume":"37","author":"Rydh","year":"2003","journal-title":"Scand. J. Urol. Nephrol."},{"key":"ref_62","first-page":"211","article-title":"Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body","volume":"6","author":"Koh","year":"2007","journal-title":"Magn. Reson. Med. Sci. MRMS Off. J. Jpn. Soc. Magn. Reson. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1593\/neo.81328","article-title":"Diffusion-weighted magnetic resonance imaging as a cancer biomarker: Consensus and recommendations","volume":"11","author":"Padhani","year":"2009","journal-title":"Neoplasia"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1148\/radiol.11110474","article-title":"Whole-body diffusion-weighted MR imaging in cancer: Current status and research directions","volume":"261","author":"Padhani","year":"2011","journal-title":"Radiology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.acra.2018.02.010","article-title":"Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases from Solid Tumors","volume":"25","author":"Jacobs","year":"2018","journal-title":"Acad. Radiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1007\/s00330-022-08536-6","article-title":"Multiparametric bone MRI can improve CT-guided bone biopsy target selection in cancer patients and increase diagnostic yield and feasibility of next-generation tumour sequencing","volume":"32","author":"Donners","year":"2022","journal-title":"Eur. Radiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmri.27596","article-title":"Metastatic Diffusion Volume Based on Apparent Diffusion Coefficient as a Prognostic Factor in Castration-Resistant Prostate Cancer","volume":"54","author":"Yamamoto","year":"2021","journal-title":"J. Magn. Reson. Imaging JMRI"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"20230240","DOI":"10.1259\/bjr.20230240","article-title":"Relative fat fraction of malignant bone lesions from breast cancer, prostate cancer and myeloma are significantly lower than normal bone marrow and shows excellent interobserver agreement","volume":"96","author":"Castagnoli","year":"2023","journal-title":"Br. J. Radiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/jmri.25496","article-title":"Measurement of fat content in vertebral marrow using a modified dixon sequence to differentiate benign from malignant processes","volume":"45","author":"Yoo","year":"2017","journal-title":"J. Magn. Reson. Imaging JMRI"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"109342","DOI":"10.1016\/j.ejrad.2020.109342","article-title":"Dixon or DWI\u2014Comparing the utility of fat fraction and apparent diffusion coefficient to distinguish between malignant and acute osteoporotic vertebral fractures","volume":"132","author":"Donners","year":"2020","journal-title":"Eur. J. Radiol."},{"key":"ref_71","unstructured":"Rizzo, A., Morbelli, S., Albano, D., Fornarini, G., Cioffi, M., Laudicella, R., Dondi, F., Grimaldi, S., Bertagna, F., and Racca, M. (2021). The Homunculus of unspecific bone uptakes associated with PSMA-targeted tracers: A systematic review-based definition. Eur. J. Nucl. Med. Mol. Imaging, ahead of printing."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.euo.2021.02.003","article-title":"Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer after Primary Radical Treatment: A Systematic Review","volume":"4","author":"Farolfi","year":"2021","journal-title":"Eur. Urol. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.clgc.2018.05.010","article-title":"Preoperative Staging with C-Choline PET\/CT Is Adequately Accurate in Patients with Very High-Risk Prostate Cancer","volume":"16","author":"Schiavina","year":"2018","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00259-021-05429-6","article-title":"[18F]-Fluciclovine PET\/CT for preoperative nodal staging in high-risk primary prostate cancer: Final results of a prospective trial","volume":"49","author":"Zanoni","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_75","first-page":"214","article-title":"Ga-PSMA PET\/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer","volume":"62","author":"Klingenberg","year":"2021","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.euf.2021.01.004","article-title":"Ga-PSMA-11 Positron Emission Tomography\/Computed Tomography for Primary Lymph Node Staging before Radical Prostatectomy: Central Review of Imaging and Comparison with Histopathology of Extended Lymphadenectomy","volume":"7","author":"Esen","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"142","DOI":"10.32471\/exp-oncology.2312-8852.vol-44-no-2.17810","article-title":"SIGNIFICANCE OF ADC MEASUREMENTS AS RADIOLOGICAL MRI MARKER IN DETECTION OF METASTATIC LYMPH NODE INVOLVEMENT IN PATIENTS WITH PROSTATE CANCER","volume":"44","author":"Mytsyk","year":"2022","journal-title":"Exp. Oncol."},{"key":"ref_78","first-page":"502","article-title":"Whole-body diffusion-weighted magnetic resonance imaging: Diagnosis and follow up of prostate cancer and beyond","volume":"28","author":"Yoshida","year":"2021","journal-title":"Int. J. Urol. Off. J. Jpn. Urol. Assoc."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/RLI.0b013e3181bbdc2f","article-title":"Preliminary results for characterization of pelvic lymph nodes in patients with prostate cancer by diffusion-weighted MR-imaging","volume":"45","author":"Eiber","year":"2010","journal-title":"Investig. Radiol."},{"key":"ref_80","first-page":"352","article-title":"Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET\/CT are correlated in pelvic lymph nodes in patients with prostate cancer","volume":"13","author":"Beer","year":"2011","journal-title":"Mol. Imaging Biol. MIB Off. Publ. Acad. Mol. Imaging"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.2015.65.7270","article-title":"Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men with Castration-Resistant Prostate Cancer","volume":"34","author":"Halabi","year":"2016","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1007\/s00259-021-05296-1","article-title":"Prospective comparison of F-PSMA-1007 PET\/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer","volume":"48","author":"Malaspina","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Adeleke, S., Latifoltojar, A., Sidhu, H., Galazi, M., Shah, T.T., Clemente, J., Davda, R., Payne, H.A., Chouhan, M.D., and Lioumi, M. (2019). Localising occult prostate cancer metastasis with advanced imaging techniques (LOCATE trial): A prospective cohort, observational diagnostic accuracy trial investigating whole-body magnetic resonance imaging in radio-recurrent prostate cancer. BMC Med. Imaging, 19.","DOI":"10.1186\/s12880-019-0380-y"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00259-019-04505-2","article-title":"Prediction nomogram for Ga-PSMA-11 PET\/CT in different clinical settings of PSA failure after radical treatment for prostate cancer","volume":"47","author":"Ceci","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.euo.2021.12.002","article-title":"Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen\/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence","volume":"6","author":"Bianchi","year":"2023","journal-title":"Eur. Urol. Oncol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00259-019-04308-5","article-title":"Prospective comparison of whole-body MRI and Ga-PSMA PET\/CT for the detection of biochemical recurrence of prostate cancer after radical prostatectomy","volume":"46","author":"Sawicki","year":"2019","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_87","first-page":"1253","article-title":"The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of F-Fluoromethylcholine or Ga-HBED-CC PSMA-11 PET\/CT in Patients with Biochemical Failure After Radical Prostatectomy","volume":"60","author":"Metser","year":"2019","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.juro.2017.02.071","article-title":"Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy","volume":"198","author":"Robertson","year":"2017","journal-title":"J. Urol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1007\/s00330-023-10442-4","article-title":"Recurrent prostate cancer: Combined role for MRI and PSMA-PET in 68Ga-PSMA-11 PET\/MRI","volume":"34","author":"Jannusch","year":"2024","journal-title":"Eur Radiol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1002\/jmri.22542","article-title":"Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: Technical feasibility and assessment of lesion conspicuity in DWI","volume":"33","author":"Eiber","year":"2011","journal-title":"J. Magn. Reson. Imaging JMRI"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/0284186X.2015.1027411","article-title":"Prospective evaluation of planar bone scintigraphy, SPECT, SPECT\/CT, 18F-NaF PET\/CT and whole body 1.5T MRI, including DWI, for the detection of bone metastases in high risk breast and prostate cancer patients: SKELETA clinical trial","volume":"55","author":"Jambor","year":"2016","journal-title":"Acta Oncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1158\/1078-0432.CCR-07-0944","article-title":"Treatment of hormone-refractory prostate cancer with docetaxel or mitoxantrone: Relationships between prostate-specific antigen, pain, and quality of life response and survival in the TAX-327 study","volume":"14","author":"Berthold","year":"2008","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1200\/JCO.2013.50.3201","article-title":"Prostate-specific antigen changes as surrogate for overall survival in men with metastatic castration-resistant prostate cancer treated with second-line chemotherapy","volume":"31","author":"Halabi","year":"2013","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00330-013-2792-3","article-title":"MRI for response assessment in metastatic bone disease","volume":"23","author":"Lecouvet","year":"2013","journal-title":"Eur. Radiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Vande Berg, B.C., Lecouvet, F.E., Galant, C., Maldague, B.E., and Malghem, J. Normal variants and frequent marrow alterations that simulate bone marrow lesions at MR imaging. Radiol. Clin. N. Am., 2005.","DOI":"10.1016\/j.rcl.2005.01.007"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2214\/ajr.165.4.7545864","article-title":"MR imaging of bone marrow in children with osteosarcoma: Effect of granulocyte colony-stimulating factor","volume":"165","author":"Ryan","year":"1995","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.3892\/ol.2015.3753","article-title":"False-positive diagnosis of disease progression by magnetic resonance imaging for response assessment in prostate cancer with bone metastases: A case report and review of the pitfalls of images in the literature","volume":"10","author":"Yu","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.mric.2010.10.004","article-title":"Diffusion MR imaging for monitoring of treatment response","volume":"19","author":"Padhani","year":"2011","journal-title":"Magn. Reson. Imaging Clin. N. Am."},{"key":"ref_99","first-page":"135","article-title":"Diffusion-weighted magnetic resonance imaging and its application to cancer","volume":"6","author":"deSouza","year":"2006","journal-title":"Cancer Imaging Off. Publ. Int. Cancer Imaging Soc."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiol.10092469","article-title":"Bone metastases from prostate cancer: Assessing treatment response by using diffusion-weighted imaging and functional diffusion maps--initial observations","volume":"257","author":"Reischauer","year":"2010","journal-title":"Radiology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00330-011-2173-8","article-title":"Assessing response in bone metastases in prostate cancer with diffusion weighted MRI","volume":"21","author":"Messiou","year":"2011","journal-title":"Eur. Radiol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1148\/radiol.2016160646","article-title":"Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study","volume":"283","author":"Mateo","year":"2017","journal-title":"Radiology"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Blackledge, M.D., Collins, D.J., Tunariu, N., Orton, M.R., Padhani, A.R., Leach, M.O., and Koh, D.-M. (2014). Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: A feasibility study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091779"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00259-018-4079-z","article-title":"Impact of long-term androgen deprivation therapy on PSMA ligand PET\/CT in patients with castration-sensitive prostate cancer","volume":"45","author":"Debus","year":"2018","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_105","first-page":"81","article-title":"68Ga-PSMA-11 PET Imaging of Response to Androgen Receptor Inhibition: First Human Experience","volume":"58","author":"Hope","year":"2017","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."},{"key":"ref_106","first-page":"950","article-title":"Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial Ga-PSMA-11 PET in Men with Hormone-Sensitive and Castrate-Resistant Prostate Cancer Commencing Androgen Blockade","volume":"60","author":"Emmett","year":"2019","journal-title":"J. Nucl. Med. Off. Publ. Soc. Nucl. Med."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/14\/2531\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:16:31Z","timestamp":1760109391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/14\/2531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,13]]},"references-count":106,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["cancers16142531"],"URL":"https:\/\/doi.org\/10.3390\/cancers16142531","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,13]]}}}